secwatch / observer
8-K filed January 11, 2023, 6:59 PM ET CIK 0001623715
M&A confidence high sentiment neutral materiality 1.00

Imago BioSciences, Inc.: M&A transaction — Merck completes $36/share acquisition of Imago BioSciences; shares delisted

Imago BioSciences, Inc.

item 2.01item 3.01item 3.03item 5.01item 5.03item 5.02item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Jon Filderman

Vice President
Imago BioSciences, Inc.
Effective
2023-01-11
Filed
January 11, 2023, 6:59 PM ET
The officers of Merger Sub immediately prior to the Effective Time were Rita A. Karachun, President, Jon Filderman, Vice President, Gary A. Henningsen, Jr., Senior Vice President – Tax , Aaron Rosenberg, Senior Vice President and Treasurer, Timothy G. Dillane, Assistant Treasurer, Juanita Lee, Assistant Treasurer, Kelly E.W. Grez, Secretary, Karen Ettelman, Assistant Secretary, Robert V. Smartwood, Assistant Treasurer and Anthony Wildasin, Assistant Secretary.
Departed

Dina Chaya, Ph.D.

Director
Imago BioSciences, Inc.
Effective
2023-01-11
Filed
January 11, 2023, 6:59 PM ET
Pursuant to the Merger Agreement, as of the Effective Time, Dennis Henner, Ph.D., Robert Baltera, M.S., Dina Chaya, Ph.D., Enoch Kariuki, Pharm.D., Hugh Y. Reinhoff, Jr., M.D. and Laurie Keating J.D. each ceased to be directors of Imago and members of any committee of Imago’s board of directors.
Departed

Laurie Keating J.D.

Director
Imago BioSciences, Inc.
Effective
2023-01-11
Filed
January 11, 2023, 6:59 PM ET
Pursuant to the Merger Agreement, as of the Effective Time, Dennis Henner, Ph.D., Robert Baltera, M.S., Dina Chaya, Ph.D., Enoch Kariuki, Pharm.D., Hugh Y. Reinhoff, Jr., M.D. and Laurie Keating J.D. each ceased to be directors of Imago and members of any committee of Imago’s board of directors.
Appointed

Gary A. Henningsen, Jr.

Senior Vice President – Tax
Imago BioSciences, Inc.
Effective
2023-01-11
Filed
January 11, 2023, 6:59 PM ET
The officers of Merger Sub immediately prior to the Effective Time were Rita A. Karachun, President, Jon Filderman, Vice President, Gary A. Henningsen, Jr., Senior Vice President – Tax , Aaron Rosenberg, Senior Vice President and Treasurer, Timothy G. Dillane, Assistant Treasurer, Juanita Lee, Assistant Treasurer, Kelly E.W. Grez, Secretary, Karen Ettelman, Assistant Secretary, Robert V. Smartwood, Assistant Treasurer and Anthony Wildasin, Assistant Secretary.
Appointed

Aaron Rosenberg

Director
Imago BioSciences, Inc.
Effective
2023-01-11
Filed
January 11, 2023, 6:59 PM ET
The directors of Merger Sub immediately prior to the Effective Time were Rita A. Karachun, Jon Filderman and Aaron Rosenberg.
Departed

Robert Baltera, M.S.

Director
Imago BioSciences, Inc.
Effective
2023-01-11
Filed
January 11, 2023, 6:59 PM ET
Pursuant to the Merger Agreement, as of the Effective Time, Dennis Henner, Ph.D., Robert Baltera, M.S., Dina Chaya, Ph.D., Enoch Kariuki, Pharm.D., Hugh Y. Reinhoff, Jr., M.D. and Laurie Keating J.D. each ceased to be directors of Imago and members of any committee of Imago’s board of directors.
Appointed

Karen Ettelman

Assistant Secretary
Imago BioSciences, Inc.
Effective
2023-01-11
Filed
January 11, 2023, 6:59 PM ET
The officers of Merger Sub immediately prior to the Effective Time were Rita A. Karachun, President, Jon Filderman, Vice President, Gary A. Henningsen, Jr., Senior Vice President – Tax , Aaron Rosenberg, Senior Vice President and Treasurer, Timothy G. Dillane, Assistant Treasurer, Juanita Lee, Assistant Treasurer, Kelly E.W. Grez, Secretary, Karen Ettelman, Assistant Secretary, Robert V. Smartwood, Assistant Treasurer and Anthony Wildasin, Assistant Secretary.
Departed

Enoch Kariuki, Pharm.D.

Director
Imago BioSciences, Inc.
Effective
2023-01-11
Filed
January 11, 2023, 6:59 PM ET
Pursuant to the Merger Agreement, as of the Effective Time, Dennis Henner, Ph.D., Robert Baltera, M.S., Dina Chaya, Ph.D., Enoch Kariuki, Pharm.D., Hugh Y. Reinhoff, Jr., M.D. and Laurie Keating J.D. each ceased to be directors of Imago and members of any committee of Imago’s board of directors.
Appointed

Jon Filderman

Director
Imago BioSciences, Inc.
Effective
2023-01-11
Filed
January 11, 2023, 6:59 PM ET
The directors of Merger Sub immediately prior to the Effective Time were Rita A. Karachun, Jon Filderman and Aaron Rosenberg.
Departed

Hugh Y. Reinhoff, Jr., M.D.

Director
Imago BioSciences, Inc.
Effective
2023-01-11
Filed
January 11, 2023, 6:59 PM ET
Pursuant to the Merger Agreement, as of the Effective Time, Dennis Henner, Ph.D., Robert Baltera, M.S., Dina Chaya, Ph.D., Enoch Kariuki, Pharm.D., Hugh Y. Reinhoff, Jr., M.D. and Laurie Keating J.D. each ceased to be directors of Imago and members of any committee of Imago’s board of directors.
Appointed

Robert V. Smartwood

Assistant Treasurer
Imago BioSciences, Inc.
Effective
2023-01-11
Filed
January 11, 2023, 6:59 PM ET
The officers of Merger Sub immediately prior to the Effective Time were Rita A. Karachun, President, Jon Filderman, Vice President, Gary A. Henningsen, Jr., Senior Vice President – Tax , Aaron Rosenberg, Senior Vice President and Treasurer, Timothy G. Dillane, Assistant Treasurer, Juanita Lee, Assistant Treasurer, Kelly E.W. Grez, Secretary, Karen Ettelman, Assistant Secretary, Robert V. Smartwood, Assistant Treasurer and Anthony Wildasin, Assistant Secretary.
Appointed

Rita A. Karachun

President
Imago BioSciences, Inc.
Effective
2023-01-11
Filed
January 11, 2023, 6:59 PM ET
The officers of Merger Sub immediately prior to the Effective Time were Rita A. Karachun, President, Jon Filderman, Vice President, Gary A. Henningsen, Jr., Senior Vice President – Tax , Aaron Rosenberg, Senior Vice President and Treasurer, Timothy G. Dillane, Assistant Treasurer, Juanita Lee, Assistant Treasurer, Kelly E.W. Grez, Secretary, Karen Ettelman, Assistant Secretary, Robert V. Smartwood, Assistant Treasurer and Anthony Wildasin, Assistant Secretary.
Appointed

Aaron Rosenberg

Senior Vice President and Treasurer
Imago BioSciences, Inc.
Effective
2023-01-11
Filed
January 11, 2023, 6:59 PM ET
The officers of Merger Sub immediately prior to the Effective Time were Rita A. Karachun, President, Jon Filderman, Vice President, Gary A. Henningsen, Jr., Senior Vice President – Tax , Aaron Rosenberg, Senior Vice President and Treasurer, Timothy G. Dillane, Assistant Treasurer, Juanita Lee, Assistant Treasurer, Kelly E.W. Grez, Secretary, Karen Ettelman, Assistant Secretary, Robert V. Smartwood, Assistant Treasurer and Anthony Wildasin, Assistant Secretary.
Appointed

Kelly E.W. Grez

Secretary
Imago BioSciences, Inc.
Effective
2023-01-11
Filed
January 11, 2023, 6:59 PM ET
The officers of Merger Sub immediately prior to the Effective Time were Rita A. Karachun, President, Jon Filderman, Vice President, Gary A. Henningsen, Jr., Senior Vice President – Tax , Aaron Rosenberg, Senior Vice President and Treasurer, Timothy G. Dillane, Assistant Treasurer, Juanita Lee, Assistant Treasurer, Kelly E.W. Grez, Secretary, Karen Ettelman, Assistant Secretary, Robert V. Smartwood, Assistant Treasurer and Anthony Wildasin, Assistant Secretary.
Appointed

Anthony Wildasin

Assistant Secretary
Imago BioSciences, Inc.
Effective
2023-01-11
Filed
January 11, 2023, 6:59 PM ET
The officers of Merger Sub immediately prior to the Effective Time were Rita A. Karachun, President, Jon Filderman, Vice President, Gary A. Henningsen, Jr., Senior Vice President – Tax , Aaron Rosenberg, Senior Vice President and Treasurer, Timothy G. Dillane, Assistant Treasurer, Juanita Lee, Assistant Treasurer, Kelly E.W. Grez, Secretary, Karen Ettelman, Assistant Secretary, Robert V. Smartwood, Assistant Treasurer and Anthony Wildasin, Assistant Secretary.
Appointed

Juanita Lee

Assistant Treasurer
Imago BioSciences, Inc.
Effective
2023-01-11
Filed
January 11, 2023, 6:59 PM ET
The officers of Merger Sub immediately prior to the Effective Time were Rita A. Karachun, President, Jon Filderman, Vice President, Gary A. Henningsen, Jr., Senior Vice President – Tax , Aaron Rosenberg, Senior Vice President and Treasurer, Timothy G. Dillane, Assistant Treasurer, Juanita Lee, Assistant Treasurer, Kelly E.W. Grez, Secretary, Karen Ettelman, Assistant Secretary, Robert V. Smartwood, Assistant Treasurer and Anthony Wildasin, Assistant Secretary.
Appointed

Timothy G. Dillane

Assistant Treasurer
Imago BioSciences, Inc.
Effective
2023-01-11
Filed
January 11, 2023, 6:59 PM ET
The officers of Merger Sub immediately prior to the Effective Time were Rita A. Karachun, President, Jon Filderman, Vice President, Gary A. Henningsen, Jr., Senior Vice President – Tax , Aaron Rosenberg, Senior Vice President and Treasurer, Timothy G. Dillane, Assistant Treasurer, Juanita Lee, Assistant Treasurer, Kelly E.W. Grez, Secretary, Karen Ettelman, Assistant Secretary, Robert V. Smartwood, Assistant Treasurer and Anthony Wildasin, Assistant Secretary.
Appointed

Rita A. Karachun

Director
Imago BioSciences, Inc.
Effective
2023-01-11
Filed
January 11, 2023, 6:59 PM ET
The directors of Merger Sub immediately prior to the Effective Time were Rita A. Karachun, Jon Filderman and Aaron Rosenberg.
Departed

Dennis Henner, Ph.D.

Director
Imago BioSciences, Inc.
Effective
2023-01-11
Filed
January 11, 2023, 6:59 PM ET
Pursuant to the Merger Agreement, as of the Effective Time, Dennis Henner, Ph.D., Robert Baltera, M.S., Dina Chaya, Ph.D., Enoch Kariuki, Pharm.D., Hugh Y. Reinhoff, Jr., M.D. and Laurie Keating J.D. each ceased to be directors of Imago and members of any committee of Imago’s board of directors.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Jon Filderman was appointed as Vice President at Imago BioSciences, Inc..

Action
appointed
Role
Vice President
Exact text from the filing
The officers of Merger Sub immediately prior to the Effective Time were Rita A. Karachun, President, Jon Filderman, Vice President, Gary A. Henningsen, Jr., Senior Vice President – Tax , Aaron Rosenberg, Senior Vice President and Treasurer, Timothy G. Dillane, Assistant Treasurer, Juanita Lee, Assistant Treasurer, Kelly E.W. Grez, Secretary, Karen Ettelman, Assistant Secretary, Robert V. Smartwood, Assistant Treasurer and Anthony Wildasin, Assistant Secretary.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Dina Chaya, Ph.D. departed as Director at Imago BioSciences, Inc..

Action
ceased to be a director
Role
Director
Exact text from the filing
Pursuant to the Merger Agreement, as of the Effective Time, Dennis Henner, Ph.D., Robert Baltera, M.S., Dina Chaya, Ph.D., Enoch Kariuki, Pharm.D., Hugh Y. Reinhoff, Jr., M.D. and Laurie Keating J.D. each ceased to be directors of Imago and members of any committee of Imago’s board of directors.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Laurie Keating J.D. departed as Director at Imago BioSciences, Inc..

Action
ceased to be a director
Role
Director
Exact text from the filing
Pursuant to the Merger Agreement, as of the Effective Time, Dennis Henner, Ph.D., Robert Baltera, M.S., Dina Chaya, Ph.D., Enoch Kariuki, Pharm.D., Hugh Y. Reinhoff, Jr., M.D. and Laurie Keating J.D. each ceased to be directors of Imago and members of any committee of Imago’s board of directors.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Gary A. Henningsen, Jr. was appointed as Senior Vice President – Tax at Imago BioSciences, Inc..

Action
appointed
Role
Senior Vice President – Tax
Exact text from the filing
The officers of Merger Sub immediately prior to the Effective Time were Rita A. Karachun, President, Jon Filderman, Vice President, Gary A. Henningsen, Jr., Senior Vice President – Tax , Aaron Rosenberg, Senior Vice President and Treasurer, Timothy G. Dillane, Assistant Treasurer, Juanita Lee, Assistant Treasurer, Kelly E.W. Grez, Secretary, Karen Ettelman, Assistant Secretary, Robert V. Smartwood, Assistant Treasurer and Anthony Wildasin, Assistant Secretary.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Aaron Rosenberg was appointed as Director at Imago BioSciences, Inc..

Action
appointed
Role
Director
Exact text from the filing
The directors of Merger Sub immediately prior to the Effective Time were Rita A. Karachun, Jon Filderman and Aaron Rosenberg.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Robert Baltera, M.S. departed as Director at Imago BioSciences, Inc..

Action
ceased to be a director
Role
Director
Exact text from the filing
Pursuant to the Merger Agreement, as of the Effective Time, Dennis Henner, Ph.D., Robert Baltera, M.S., Dina Chaya, Ph.D., Enoch Kariuki, Pharm.D., Hugh Y. Reinhoff, Jr., M.D. and Laurie Keating J.D. each ceased to be directors of Imago and members of any committee of Imago’s board of directors.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Karen Ettelman was appointed as Assistant Secretary at Imago BioSciences, Inc..

Action
appointed
Role
Assistant Secretary
Exact text from the filing
The officers of Merger Sub immediately prior to the Effective Time were Rita A. Karachun, President, Jon Filderman, Vice President, Gary A. Henningsen, Jr., Senior Vice President – Tax , Aaron Rosenberg, Senior Vice President and Treasurer, Timothy G. Dillane, Assistant Treasurer, Juanita Lee, Assistant Treasurer, Kelly E.W. Grez, Secretary, Karen Ettelman, Assistant Secretary, Robert V. Smartwood, Assistant Treasurer and Anthony Wildasin, Assistant Secretary.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Enoch Kariuki, Pharm.D. departed as Director at Imago BioSciences, Inc..

Action
ceased to be a director
Role
Director
Exact text from the filing
Pursuant to the Merger Agreement, as of the Effective Time, Dennis Henner, Ph.D., Robert Baltera, M.S., Dina Chaya, Ph.D., Enoch Kariuki, Pharm.D., Hugh Y. Reinhoff, Jr., M.D. and Laurie Keating J.D. each ceased to be directors of Imago and members of any committee of Imago’s board of directors.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Jon Filderman was appointed as Director at Imago BioSciences, Inc..

Action
appointed
Role
Director
Exact text from the filing
The directors of Merger Sub immediately prior to the Effective Time were Rita A. Karachun, Jon Filderman and Aaron Rosenberg.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Hugh Y. Reinhoff, Jr., M.D. departed as Director at Imago BioSciences, Inc..

Action
ceased to be a director
Role
Director
Exact text from the filing
Pursuant to the Merger Agreement, as of the Effective Time, Dennis Henner, Ph.D., Robert Baltera, M.S., Dina Chaya, Ph.D., Enoch Kariuki, Pharm.D., Hugh Y. Reinhoff, Jr., M.D. and Laurie Keating J.D. each ceased to be directors of Imago and members of any committee of Imago’s board of directors.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Robert V. Smartwood was appointed as Assistant Treasurer at Imago BioSciences, Inc..

Action
appointed
Role
Assistant Treasurer
Exact text from the filing
The officers of Merger Sub immediately prior to the Effective Time were Rita A. Karachun, President, Jon Filderman, Vice President, Gary A. Henningsen, Jr., Senior Vice President – Tax , Aaron Rosenberg, Senior Vice President and Treasurer, Timothy G. Dillane, Assistant Treasurer, Juanita Lee, Assistant Treasurer, Kelly E.W. Grez, Secretary, Karen Ettelman, Assistant Secretary, Robert V. Smartwood, Assistant Treasurer and Anthony Wildasin, Assistant Secretary.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Rita A. Karachun was appointed as President at Imago BioSciences, Inc..

Action
appointed
Role
President
Exact text from the filing
The officers of Merger Sub immediately prior to the Effective Time were Rita A. Karachun, President, Jon Filderman, Vice President, Gary A. Henningsen, Jr., Senior Vice President – Tax , Aaron Rosenberg, Senior Vice President and Treasurer, Timothy G. Dillane, Assistant Treasurer, Juanita Lee, Assistant Treasurer, Kelly E.W. Grez, Secretary, Karen Ettelman, Assistant Secretary, Robert V. Smartwood, Assistant Treasurer and Anthony Wildasin, Assistant Secretary.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Aaron Rosenberg was appointed as Senior Vice President and Treasurer at Imago BioSciences, Inc..

Action
appointed
Role
Senior Vice President and Treasurer
Exact text from the filing
The officers of Merger Sub immediately prior to the Effective Time were Rita A. Karachun, President, Jon Filderman, Vice President, Gary A. Henningsen, Jr., Senior Vice President – Tax , Aaron Rosenberg, Senior Vice President and Treasurer, Timothy G. Dillane, Assistant Treasurer, Juanita Lee, Assistant Treasurer, Kelly E.W. Grez, Secretary, Karen Ettelman, Assistant Secretary, Robert V. Smartwood, Assistant Treasurer and Anthony Wildasin, Assistant Secretary.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Kelly E.W. Grez was appointed as Secretary at Imago BioSciences, Inc..

Action
appointed
Role
Secretary
Exact text from the filing
The officers of Merger Sub immediately prior to the Effective Time were Rita A. Karachun, President, Jon Filderman, Vice President, Gary A. Henningsen, Jr., Senior Vice President – Tax , Aaron Rosenberg, Senior Vice President and Treasurer, Timothy G. Dillane, Assistant Treasurer, Juanita Lee, Assistant Treasurer, Kelly E.W. Grez, Secretary, Karen Ettelman, Assistant Secretary, Robert V. Smartwood, Assistant Treasurer and Anthony Wildasin, Assistant Secretary.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Anthony Wildasin was appointed as Assistant Secretary at Imago BioSciences, Inc..

Action
appointed
Role
Assistant Secretary
Exact text from the filing
The officers of Merger Sub immediately prior to the Effective Time were Rita A. Karachun, President, Jon Filderman, Vice President, Gary A. Henningsen, Jr., Senior Vice President – Tax , Aaron Rosenberg, Senior Vice President and Treasurer, Timothy G. Dillane, Assistant Treasurer, Juanita Lee, Assistant Treasurer, Kelly E.W. Grez, Secretary, Karen Ettelman, Assistant Secretary, Robert V. Smartwood, Assistant Treasurer and Anthony Wildasin, Assistant Secretary.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Juanita Lee was appointed as Assistant Treasurer at Imago BioSciences, Inc..

Action
appointed
Role
Assistant Treasurer
Exact text from the filing
The officers of Merger Sub immediately prior to the Effective Time were Rita A. Karachun, President, Jon Filderman, Vice President, Gary A. Henningsen, Jr., Senior Vice President – Tax , Aaron Rosenberg, Senior Vice President and Treasurer, Timothy G. Dillane, Assistant Treasurer, Juanita Lee, Assistant Treasurer, Kelly E.W. Grez, Secretary, Karen Ettelman, Assistant Secretary, Robert V. Smartwood, Assistant Treasurer and Anthony Wildasin, Assistant Secretary.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Timothy G. Dillane was appointed as Assistant Treasurer at Imago BioSciences, Inc..

Action
appointed
Role
Assistant Treasurer
Exact text from the filing
The officers of Merger Sub immediately prior to the Effective Time were Rita A. Karachun, President, Jon Filderman, Vice President, Gary A. Henningsen, Jr., Senior Vice President – Tax , Aaron Rosenberg, Senior Vice President and Treasurer, Timothy G. Dillane, Assistant Treasurer, Juanita Lee, Assistant Treasurer, Kelly E.W. Grez, Secretary, Karen Ettelman, Assistant Secretary, Robert V. Smartwood, Assistant Treasurer and Anthony Wildasin, Assistant Secretary.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Rita A. Karachun was appointed as Director at Imago BioSciences, Inc..

Action
appointed
Role
Director
Exact text from the filing
The directors of Merger Sub immediately prior to the Effective Time were Rita A. Karachun, Jon Filderman and Aaron Rosenberg.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Dennis Henner, Ph.D. departed as Director at Imago BioSciences, Inc..

Action
ceased to be a director
Role
Director
Exact text from the filing
Pursuant to the Merger Agreement, as of the Effective Time, Dennis Henner, Ph.D., Robert Baltera, M.S., Dina Chaya, Ph.D., Enoch Kariuki, Pharm.D., Hugh Y. Reinhoff, Jr., M.D. and Laurie Keating J.D. each ceased to be directors of Imago and members of any committee of Imago’s board of directors.
View on SEC.gov
Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Imago BioSciences, Inc.: Amended and restated by-laws in their entirety.

Change
bylaw amendment
Exact text from the filing
Imago’s by-laws, as in effect immediately prior to the Effective Time, were amended and restated in their entirety (the “Second Amended and Restated By-Laws”).
View on SEC.gov
Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Imago BioSciences, Inc.: Amended and restated certificate of incorporation in its entirety.

Change
charter amendment
Exact text from the filing
Imago’s certificate of incorporation, as in effect immediately prior to the Effective Time, was amended and restated in its entirety (the “Second Amended and Restated Certificate of Incorporation”).
View on SEC.gov
M&A Transactions SEC 8-K Item 2.01/5.01 confidence 0.9

Imago BioSciences, Inc. completed an acquisition involving Merck Sharp & Dohme LLC for $36.00 per share in cash (closed 2023-01-11).

Action
acquisition
Counterparty
Merck Sharp & Dohme LLC
Consideration
$36.00 per share in cash
Closing
2023-01-11
Exact text from the filing
Merger Sub commenced a tender offer (the “Offer”) on December 12, 2022 to acquire all of the outstanding shares of Imago’s common stock (the “Shares”) for a purchase price of $36.00 per Share, to the seller in cash, without interest and subject to any required tax withholding (the “Offer Price”). The Offer and related withdrawal rights expired as scheduled at
View on SEC.gov

Browse all governance changes →

Source: SEC EDGAR
accession 0001193125-23-006137
view filing index on sec.gov
view primary document
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.